Fifteen measles instances — largely in school-aged youngsters — have been confirmed in a small county in West Texas with one of many highest charges of vaccine exemptions within the state. South Plains Public Well being District Director Zach Holbrooks stated Monday that his division was first notified in late January in regards to the … Read more
By Brad Sorensen, CFA NASDAQ:LGVN READ THE FULL LGVN RESEARCH REPORT Longeveron (NASDAQ:LGVN) has been beneath the management of a brand new CEO for simply over a 12 months, with Mr. Hashad not too long ago issuing a letter to shareholders marking the milestone. We now have been telling buyers in regards to the nice … Read more
By David Bautz, PhD NASDAQ:SNGX READ THE FULL SNGX RESEARCH REPORT Enterprise Replace Reaches Settlement with European Medicines Company on Second Confirmatory Trial for HyBryte On April 3, 2024, Soligenix, Inc. (NASDAQ:SNGX) introduced it has reached settlement with the European Medicines Company (EMA) on the important thing design parts for a confirmatory Part 3 trial … Read more
By David Bautz, PhD NASDAQ:IMNN READ THE FULL IMNN RESEARCH REPORT Enterprise Replace Replace on IMNN-101 Imunon, Inc. (NASDAQ:IMNN) is growing IMNN-101, which is a COVID-19 seasonal vaccine booster based mostly on the corporate’s PlaCCine know-how. It’s a DNA vaccine that addresses plenty of limitations of present vaccines, together with the sturdiness of antigen expression, … Read more
By David Bautz, PhD NASDAQ:CRVO READ THE FULL CRVO RESEARCH REPORT Enterprise Replace Biomarker Knowledge Introduced at AD/PD 2024 On March 5, 2024, CervoMed Inc. (NASDAQ:CRVO) introduced the presentation of biomarker knowledge from the AscenD-LB Part 2a trial of neflamapimod in sufferers with dementia with Lewy our bodies (DLB) was featured in a poster presentation … Read more
